GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beit Jala Pharmaceutical Co (XPAE:BJP) » Definitions » EBITDA Margin %

Beit Jala Pharmaceutical Co (XPAE:BJP) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Beit Jala Pharmaceutical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Beit Jala Pharmaceutical Co's EBITDA for the six months ended in . 20 was JOD0.00 Mil. Beit Jala Pharmaceutical Co's Revenue for the six months ended in . 20 was JOD0.00 Mil. Therefore, Beit Jala Pharmaceutical Co's EBITDA margin for the quarter that ended in . 20 was 0.00%.


Beit Jala Pharmaceutical Co EBITDA Margin % Historical Data

The historical data trend for Beit Jala Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beit Jala Pharmaceutical Co EBITDA Margin % Chart

Beit Jala Pharmaceutical Co Annual Data
Trend
EBITDA Margin %

Beit Jala Pharmaceutical Co Semi-Annual Data
EBITDA Margin %

Competitive Comparison of Beit Jala Pharmaceutical Co's EBITDA Margin %

For the Biotechnology subindustry, Beit Jala Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beit Jala Pharmaceutical Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beit Jala Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Beit Jala Pharmaceutical Co's EBITDA Margin % falls into.


;
;

Beit Jala Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Beit Jala Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Beit Jala Pharmaceutical Co's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beit Jala Pharmaceutical Co  (XPAE:BJP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Beit Jala Pharmaceutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Beit Jala Pharmaceutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beit Jala Pharmaceutical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
81, Al-Madares Street, Beit Jala, West Bank, Beit Jala, PSE, 97300
Beit Jala Pharmaceutical Co is a manufacturer of pharmaceutical products. The company's products include tablets, capsules, powders, syrups, solutions, oral drops, creams, gels, lotions, medicated shampoo, suppositories and ointments.

Beit Jala Pharmaceutical Co Headlines

No Headlines